JBBS  Vol.3 No.8 , December 2013
Exposure to Hypobaric Hypoxia and Reoxygenation Induces Transient Anxiety-Like Behavior in Rat
Abstract: Chronic exposure to hypobaric hypoxia (HH) causes memory impairment and prolonged state of mental confusion. However, effect of high altitude exposure on mood state and its underlying mechanisms have been poorly studied.  Present study was undertaken to investigate the mood state alteration following chronic exposure to HH. Male Sprague Dawley rats were divided into five groups and exposed to hypoxia for 3, 7, 14 and 21 days in an animal decompression chamber at an altitude of 25,000ft. Anxiety-and depression-like behaviors were assessed by using various mazes along with changes in serotonin and glutamate level. Our study revealed a decrease in exploratory, grooming and rearing behavior in open field test following initial exposure to HH for 7 days without affecting the locomotory behavior. Initial exposure to HH-decreased time spent in open arm of elevated plus maze indicating induction of anxiety-like behavior which normalized on prolonged hypoxic exposure for 21 days. Hypoxic exposure for 7 days induced anhedonia and increased despair behavior in rat while there was steady improvement in these behaviors when exposed for 21 days. Decrease in serotonin level was noted in hippocampus along with elevated corticosterone and glutamate level which gradually decreased on prolonged exposure to HH. These findings suggest that initial exposure to HH increases transient anxiety-like behavior in rats followed by gradual improvement in mood state on prolonged exposure. Further, the study also indicates the involvement of serotonergic system in mood state alteration at high altitude following chronic exposure and reoxygenation.
Cite this paper: I. Baitharu, V. Jain, S. Deep, G. Kumar and G. Ilavazhagan, "Exposure to Hypobaric Hypoxia and Reoxygenation Induces Transient Anxiety-Like Behavior in Rat," Journal of Behavioral and Brain Science, Vol. 3 No. 8, 2013, pp. 591-602. doi: 10.4236/jbbs.2013.38063.

[1]   R. W. Baumgartner, V. Eivhenberger and P. Bartsch, “Postural Ataxia at High Altitude Is Not Related to Mild to Moderate Acute Mountain Sickness,” European Journal of Applied Physiology, Vol. 86, 2002, pp. 322-326.

[2]   D. M. Baily and B. Davies, “Acute Mountain Sickness, Prophylactic Benefits of Antioxidant Vitamin Supplementation at High Altitude,” High Altitude Medicine Biology, Vol. 2, 2001, pp. 21-29.

[3]   X. Y. Li, X. Y. Wu, C. Fu, X. F. Shen, C. B. Yang and Y. H. Wu, “Effects of Acute Exposure to Mild or Moderate Hypoxia on Human Psychomotor Performance and Visual-Reaction Time,” Space Medicine and Medical Engineering (Beijing), Vol. 13, No. 4, 2000, pp. 235-239.

[4]   M. Bahrke and B. S. Hale, “Effect of Altitude on Mood, Behavior and Cognitive Functioning,” Sports Medicine, Vol. 16, 1993, pp. 97-125.

[5]   A. J. Hamilton, L. A. Trad and A. Cymerman, “Alterations in Human Upper Extremity Motor Function during Acute Exposure to Simulated Altitude,” Aviation and Space Environmental Medicine, Vol. 62, 1991, pp.759-764.

[6]   S. B. Singh and W. Selvamurthy, “Effect of Intermittent Chronic Exposure to Hypoxia on Feeding Behavior of Rats,” International Journal of Biometeorology, Vol. 37, 1993, pp. 200-202.

[7]   L. Thakur, K. Ray, J. P. Anand and U. Panjwani, “Event Related Potential (ERP) P300 after 6 Months Residence at 4115 Meter,” Indian Journal of Medical Research, Vol. 134, No. 1, 2011, pp. 113-117.

[8]   S. Muthuraju, P. Maiti, P. Solanki, A. K. Sharma, S. B. Singh, D. Prasad and G. Ilavazhagan, “Cholinesterase Inhibitors Ameliorate Spatial Learning Deficits in Rats Following HH,” Experimental Brain Research, Vol. 203, No. 3, 2010, pp. 583-592.

[9]   K. Barhwal, S. K. Hota, I. Baitharu, D. Prasad, S. B. Singh and G. Ilavazhagan, “Isradipine Antagonizes HH Induced CA1 Damage and Memory Impairment: Complementary hotaroles of L-Type Calcium Channel and NMDA Receptors,” Neurobiology of Disease, Vol. 34, 2009, pp. 230-244.

[10]   V. Krishnan and E. J. Nestler, “The Molecular Neurobiology of Depression,” Nature, Vol. 455, 2008, pp. 894-902.

[11]   P. L. Delgado, “Depression: The Case for a Monoamine Deficiency,” Journal of Clinical Psychiatry, Vol. 6, 2006, pp. 7-11.

[12]   C. Alexandre, D. Popa, V. Fabre, S. Bouali, P. Venault, K. P. Lesch, M. Hamon and J. Adrien, “Early Life Blockade of 5-Hydroxytryptamine 1A Receptors Normalizes Sleep and Depression-Like Behavior in Adult Knock-Out Mice Lacking the Serotonin Transporter,” Journal of Neuroscience, Vol. 26, 2006, pp. 5554-5564.

[13]   E. I. Flandreau, K. J. Ressler, M. J. Owens and C. B. Nemeroff, “Chronic Overexpression of Corticotropin-Releasing Factor from the Central Amygdala Produces HPA Axis Hyperactivity and Behavioral Anxiety Associated with Gene-Expression Changes in the Hippocampus and Paraventricular Nucleus of the Hypothalamus,” Psychoneuroendocrinology, Vol. 37, 2012, pp. 27-38.

[14]   I. Baitharu, S. N. Deep, V. Jain, K. Barhwal, A. S. Malhotra, S. K. Hota, D. Prasad and G. Ilavazhagan, “Corticosterone Synthesis Inhibitor Metyrapone Ameliorates Chronic Hypobaric Hypoxia Induced Memory Impairment in Rat,” Behavioral Brain Research, Vol. 228, 2012, pp. 53-65.

[15]   I. Baitharu, S. N. Deep, V. Jain, D. Prasad and G. Ilavazhagan, “Inhibition of Glucocorticoid Receptors Ameliorates Hypobaric Hypoxia Induced Memory Impairment in Rat,” Behavioral Brain Research, Vol. 240, 2013, pp. 76-86.

[16]   W. N. Marsden, “Stressor-Induced NMDAR dysfunction as a Unifying Hypothesis for the Aetiology, Pathogenesis and Comorbidity of Clinical Depression,” Medical Hypotheses, 2011, p. 7.

[17]   S. K. Hota, K. Barhwal, I. Baitharu, D. Prasad, S. B. Singh and G. Ilavazhagan, “Bacopa Monniera Leaf Extract Ameliorates Hypobaric Hypoxia Induced Spatial Memory Impairment,” Neurobiology of Disease. Vol. 34, 2009, pp. 23-39.

[18]   A. V. Kalueff, T. Keisala, A. Minasyan, M. Kuuslahti and P. Tuohimaa, “Temporal Stability of Novelty Exploration in Mice Exposed to Different Open Field Tests,” Behavioral Processes, Vol. 72, No. 1, 2006, pp. 104-112.

[19]   J. C. O’Connor, M. A. Lawson, C. Andre, M. Moreau, J. Lestage, N. Castanon, K. W. Kelley and R. Dantzer, “Lipopolysaccharide-Induced Depressive-Like Behavior Is Mediated by Indoleamine 2,3-Dioxygenase Activation in Mice,” Molecular Psychiatry, Vol. 14, 2009, pp. 511-522.

[20]   Y. N. Wong, B. M. Chien and A. P. D’mello, “Analysis of Corticosterone in Rat Plasma by High-Performance Liquid Chromatography,” Journal of Chromatography B: Biomedical Application, Vol. 661, No. 2, 1994, pp. 211-218.

[21]   A. Mishra and K. P. Roy, “2-OHE2-Induced Oocyte Maturation Involves Steroidogenesis in Cat Fish,” Journal of Endocrinology, Vol. 189, 2006, pp. 341-353.

[22]   B. A. Gaudiano, D. Young, I. Chelminski and M. Zimmerman, “Depressive Symptom Profiles and Severity Patterns in Outpatients with Psychotic vs Nonpsychotic Major Depression,” Comparative Psychiatry, Vol. 49, 2008, pp. 421-429.

[23]   G. M. Saletu-Zyhlarz, P. Anderer, O. Arnold and B. Saletu, “Confirmation of the Neurophysiologically Predicted Therapeutic Effects of Trazodone on Its Target Symptoms Depression, Anxiety and Insomnia by Postmarketing Clinical Studies with a Controlled-Release Formulation in Depressed Outpatients,” Neuropsychobiology, Vol. 48, 2003, pp. 194-208.

[24]   M. K. Sun and D. L. Alkon, “Induced Depressive Behavior Impairs Learning and Memory in Rats,” Neuroscience, Vol. 129, No. 1, 2004, pp. 129-139.

[25]   C. Song, X. Y. Zhang and M. Manku, “Increased Phospholipase A2 Activity and Inflammatory Response But Decreased Nerve Growth Factor Expression in the Olfactory Bulbectomized Rat Model of Depression: Effects of Chronic Ethyl-Eicosapentaenoate Treatment,” Journal of Neurosciences, Vol. 29, No. 1, 2009, pp. 14-22.

[26]   R. J. Katz, K. A. Roth and B. J. Carroll, “Acute and Chronic Stress Effects on Open Field Activity in the Rat: Implications for a Model of Depression,” Neuroscience and Biobehavioral Review, Vol. 5, 1981, pp. 247-251.

[27]   W. P. Paré and G. B. Glavin, “Restraint Stress in Biomedical Research: A Review,” Neuroscience & Biobehavioral Reviews, Vol. 10, No. 3, 1986, pp. 339-370.

[28]   C. Chotiwat and R. B. Harris, “Increased Anxiety-Like Behavior during the Post-Stress Period in Mice Exposed to Repeated Restraint Stress,” Hormone and Behaviour, Vol. 50, 2006, pp. 489-495.

[29]   P. Willner, “Validity, Reliability and Utility of the Chronic mild Stress Model of Depression: A 10-Year Review and Evaluation,” Psychopharmacology (Berl), Vol. 134, 1997, pp. 319-329.

[30]   T. Strekalova, R. Spanagel, D. Bartsch, F. A. Henn and P. Gass, “Stress-Induced Anhedonia in Mice is Associated with Deficits in Forced Swimming and Exploration,” Neuropsychopharmacology, Vol. 29, No. 11, 2004, pp. 2007-2017.

[31]   S. Scheggi, G. Marchese, F. Borsini, F. Bordi and M. G. De Montis, “Effects of the 5-HT(6) Receptor Agonist ST 1936 on Depressionand Anhedonia-like Experimental Models,” Behavioral Brain Research, Vol. 224, No. 1, 2011, pp. 35-43.

[32]   E. Poleszak, P. Wlaz, E. Kedzierska, D. Nieoczym, E. Wyska, J. Szymura-Oleksiak, S. Fidecka, M. Radziwoń-Zaleska and G. Nowak, “Immobility Stress Induces Depression-Like Behavior in the Forced Swim Test in Mice: Effect of Magnesium and Imipramine,” Pharmacology Report, Vol. 58, No. 5, 2006, pp. 746-752.

[33]   S. Sevgi, M. Ozek and L. Eroglu, “L-NAME Prevents Anxiety-Like and Depression-Like Behavior in Rats Exposed to Restraint Stress,” Methods Find Experimental Clinical Pharmacology, Vol. 28, No. 2, 2006, pp. 95-99.

[34]   Y. Zhao, R. Ma, J. Shen, H. Su, D. Xing and L. Du, “A Mouse Model of Depression Induced by Repeated Corticosterone Injections,” European Journal of Pharmacology, Vol. 581, No. 1-2, 2008, pp. 113-120.

[35]   M. Nicolas, F. Thullier-Lestienne, C. Bouquet, B. Gardette, C. Gortan, F. Joulia, M. Bonnon, J. P. Richalet, P. Therme and J. H. Abraini, “An Anxiety, Personality and Altitude Symptomatology Study during a 31-day Period of Hypoxia in a Hypobaric Chamber (Experiment ‘Everest-Comex 1997’),” Journal of Environmental Psychology, Vol. 19, No. 4, 1999, pp. 407-414.

[36]   B. L. Shukitt and L. E. Banderet, “Mood States at 1600 and 4300 Meters Terrestrial Altitude,” Aviation, Space and Environmental Medicine, Vol. 59, No. 6, 1988, pp. 530-532.

[37]   J. Fawcett and H. M. Kravitz, “Anxiety Syndromes and Their Relationship to Depressive Illness,” Journal of Clinical Psychiatry, Vol. 44, No. 8, 1983, pp. 8-11.

[38]   A. J. Dunn and A. H. Swiergiel, “Effects of Acute and Chronic Stressors and CRF in Rat and Mouse Tests for Depression,” Annals of New York Academy of Sciences, Vol. 1148, 2008, pp. 118-126.

[39]   M. Banasr and R. S. Duman, “Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-Like Behaviors,” Biological Psychiatry, Vol. 64, No. 10, 2008, pp. 863-870.

[40]   E. A. O’Connor, E. P. Whitlock, T. L. Beil and B. N. Gaynes, “Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review,” Annals of Internal Medicine, Vol. 151, No. 2009, pp. 793-803.

[41]   P. Maiti, S. Muthuraju, G. Ilavazhagan and S. B. Singh, “Hypobaric Hypoxia Induces Dendritic Plasticity in Cortical and Hippocampal Pyramidal Neurons in Rat Brain,” Behavioural Brain Research, Vol. 189, No. 2, 2008, pp. 233-243.

[42]   L. Song, W. Che, W. Min-Wei, Y. Murakami and K. Matsumoto, “Impairment of the Spatial Learning and Memory Induced by Learned Helplessness and Chronic Mild Stress,” Pharmacology Biochemistry and Behavior, Vol. 83, No. 2, 2006, pp. 186-193.

[43]   J. M. Gorman and J. M. Kent, “SSRIs and SNRIs: Broad Spectrum of Efficacy beyond Major Depression,” Journal of Clinical Psychiatry, Vol. 60, No. 4, 1999, pp. 33-38.

[44]   B. Shukitt-Hale, L. E. Banderet and H. R. Lieberman, “Elevation-Dependent Symptom, Mood, and Performance Changes Produced by Exposure to Hypobaric Hypoxia,” International Journal of Aviation Psychology, Vol. 8, No. 4, 1998, pp. 319-334.

[45]   X. H. Zhu, H. C. Yan, J. Zhang, H. D. Qu, X. S. Qiu, L. Chen, S. J. Li, X. Cao, J. C. Bean, L. H. Chen, X. H. Qin, J. H., Liu, X. C. Bai, L. Mei and T. M. Gao, “Intermittent Hypoxia Promotes Hippocampal Neurogenesis and Produces Antidepressant-Like Effects in Adult Rats,” Journal of Neuroscience, Vol. 30, No. 38, 2010, pp. 12653-12663.

[46]   E. Rybnikova, V. Mironova, S. Pivina, E. Tulkova, N. Ordyan, N. Nalivaeva, A. Turner and M. Samoilov, “Involvement of the Hypothalamic-Pituitary-Adrenal Axis in the Antidepressant-Like Effects of Mild Hypoxic Preconditioning in Rats,” Psychoneuroendocrinology, Vol. 32, No. 7, 2007, pp. 813-823.

[47]   E. A. Rybnikova, M. O. Samoilov, V. I Mironova, E. I Tyul’kova, S. G. Pivina, L. A. Vataeva, N. E. Ordyan, E. Y. Abritalin and A. I. Kolchev, “The Possible Use of Hypoxic Preconditioning for the Prophylaxis of Post-Stress Depressive Episodes,” Neuroscience and Behavioral Physiology, Vol. 38, No. 7, 2008, pp. 721-726.

[48]   N. Calvo, I. D. Martijena, V. A. Molina and M. Volosin, “Metyrapone Pretreatment Prevents the Behavioral and Neurochemical Sequel Induced by Stress,” Brain Research, Vol. 800, No. 2, 1998, pp. 227-235.